{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-3081"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-3081","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"An Open Label Study of the Effects of Levetiracetam in Children with Autism","abstract":"This was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was to test the following research questions: (1) to determine whether levetiracetam reduces problematic externalizing behaviors in children with autism, and (2) to determine whether a nootropic effect from levetiracetam may be seen in cognition, memory, and/or language function in children with autism. Evaluations were gathered pre-treatment and during treatment using a battery of cognitive and behavioral measures. During-treatment evaluations were performed after an average of 4.1 weeks taking levetiracetam. Data were analyzed using one-tailed, Student's correlated samples t-tests. Levetiracetam improves hyperactivity, impulsivity and mood stability features of autism. Sensory response measures were significantly worse with treatment. A nootropic effect was not found. Further study is indicated using a double blind, placebo-controlled research design.","abstract_html":"This was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was to test the following research questions: (1) to determine whether levetiracetam reduces problematic externalizing behaviors in children with autism, and (2) to determine whether a nootropic effect from levetiracetam may be seen in cognition, memory, and/or language function in children with autism. Evaluations were gathered pre-treatment and during treatment using a battery of cognitive and behavioral measures. During-treatment evaluations were performed after an average of 4.1 weeks taking levetiracetam. Data were analyzed using one-tailed, Student&#x27;s correlated samples t-tests. Levetiracetam improves hyperactivity, impulsivity and mood stability features of autism. Sensory response measures were significantly worse with treatment. A nootropic effect was not found. Further study is indicated using a double blind, placebo-controlled research design.","abstract_has_math":false,"creators":["Samsock, Teresa C."],"institution":null,"degree_name":"Psychology","degree_level":"Thesis","degree_discipline":"College of Liberal Arts","degree_department":null,"school":null,"contributors":["Marianna Footo-Linz","Stephen P. Mewalett"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:30Z","subjects":["Chemicals and Drugs","Clinical Psychology","Experimental Analysis of Behavior","Medicine and Health Sciences","Psychology","Social and Behavioral Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/2076","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/2076","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-3081","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Marianna Footo-Linz","Stephen P. Mewalett"]},{"key":"dc:creator","label":"Author","values":["Samsock, Teresa C."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-05-20T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2001-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["College of Liberal Arts"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Psychology"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Chemicals and Drugs","Clinical Psychology","Experimental Analysis of Behavior","Medicine and Health Sciences","Psychology","Social and Behavioral Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/2076"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was to test the following research questions: (1) to determine whether levetiracetam reduces problematic externalizing behaviors in children with autism, and (2) to determine whether a nootropic effect from levetiracetam may be seen in cognition, memory, and/or language function in children with autism. Evaluations were gathered pre-treatment and during treatment using a battery of cognitive and behavioral measures. During-treatment evaluations were performed after an average of 4.1 weeks taking levetiracetam. Data were analyzed using one-tailed, Student's correlated samples t-tests. Levetiracetam improves hyperactivity, impulsivity and mood stability features of autism. Sensory response measures were significantly worse with treatment. A nootropic effect was not found. Further study is indicated using a double blind, placebo-controlled research design."]},{"key":"dc:title","label":"Title","values":["An Open Label Study of the Effects of Levetiracetam in Children with Autism"]}]}],"canonical_facts":{"dc:contributor":["Marianna Footo-Linz","Stephen P. Mewalett"],"dc:creator":["Samsock, Teresa C."],"dc:date.available":["2026-05-20T07:00:00Z"],"dc:date.created":["2001-01-01T08:00:00Z"],"dc:description.abstract":["This was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was to test the following research questions: (1) to determine whether levetiracetam reduces problematic externalizing behaviors in children with autism, and (2) to determine whether a nootropic effect from levetiracetam may be seen in cognition, memory, and/or language function in children with autism. Evaluations were gathered pre-treatment and during treatment using a battery of cognitive and behavioral measures. During-treatment evaluations were performed after an average of 4.1 weeks taking levetiracetam. Data were analyzed using one-tailed, Student's correlated samples t-tests. Levetiracetam improves hyperactivity, impulsivity and mood stability features of autism. Sensory response measures were significantly worse with treatment. A nootropic effect was not found. Further study is indicated using a double blind, placebo-controlled research design."],"dc:identifier":["https://mds.marshall.edu/etd/2076"],"dc:subject":["Chemicals and Drugs","Clinical Psychology","Experimental Analysis of Behavior","Medicine and Health Sciences","Psychology","Social and Behavioral Sciences"],"dc:title":["An Open Label Study of the Effects of Levetiracetam in Children with Autism"],"thesis:degree_discipline":["College of Liberal Arts"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Psychology"]},"updated_at":"2026-11-21T19:58:30Z"}